RaySearch Laboratories AB (publ)
STO:RAY B
Relative Value
The Relative Value of one
RAY B
stock under the Base Case scenario is
182.29
SEK.
Compared to the current market price of 188 SEK,
RaySearch Laboratories AB (publ)
is
Overvalued by 3%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RAY B Competitors Multiples
RaySearch Laboratories AB (publ) Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
RaySearch Laboratories AB (publ)
STO:RAY B
|
6.4B SEK | 4.8 | 28.3 | 21.7 | 21.7 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | 21.9 | 43.2 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
30.5B USD | 9.5 | 33.3 | 24.1 | 25 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
13.1B AUD | 52.7 | 55.9 | 69.1 | 69.1 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 3.3 | 22.6 | 11.1 | 13.5 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.7B USD | 4.2 | 41.2 | 14.9 | 22.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
44B SEK | 18.8 | 81.8 | -112.8 | -112.8 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 7.2 | 19.2 | 15.3 | 16.1 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
20B CNY | 9.3 | -65.1 | -128.7 | -128.7 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.9 | -328 | 267.9 | 4 290.1 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
230.4B INR | 7.5 | 34.7 | 22.9 | 25.8 |